Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Transforming Growth Factor alpha (compound)
Most Correlated Studies
- ERK oscillation-dependent gene expression patterns
- L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast SKBR3 cells treated with ligand perturbagens
- L1000 CMAP - Fibrocystic disease of breast MCF10A cells treated with ligand perturbagens
Most Relevant Literature
- Prostate cancer expressing membrane-bound TGF-α induces bone formation mediated by the autocrine eff…
- Bisacodyl Suppresses TGF-α-Induced MUC5AC Production in NCI-H292 Cells.
- The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Progn…
- Transforming growth factor-alpha does not protect myocardium during acute ischemia/reperfusion.
- Role of Lactoferrin in Treatment of Bile Duct Ligation-Induced Hepatic Fibrosis in Rats: Impact on I…
Most Relevant Clinical Trials
- Tumor Growth Factors in Hepatocellular Carcinoma
- Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tea…
- Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Tr…
- Sustainable Intervention of Supplementation to Improve Kid's Growth Study
- Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immuno…
